Congenital Adrenal Hyperplasia Associated with POR Gene Mutation:a Case Report and Literature Review
Department of Endocrinology and Metabolic Diseases,the First Affiliated Hospital of Anhui Medical University,Hefei 230000,China
*Corresponding author:HU Honglin,Chief physician,Master supervisor;E-mail:hhlin1994@sina.com
QI Qi,HU Honglin,XU Min, et al. Congenital Adrenal Hyperplasia Associated with POR Gene Mutation:a Case Report and Literature Review [J]. Chinese General Practice, 2021, 24(30): 3900-3904. DOI: 10.12114/j.issn.1007-9572.2021.00.567.
齐琪,胡红琳,许敏等. 细胞色素P450氧化还原酶基因突变致先天性肾上腺皮质增生症一例报道并文献复习[J]. 中国全科医学, 2021, 24(30): 3900-3904. DOI: 10.12114/j.issn.1007-9572.2021.00.567.
[1]KRONE N,DHIR V,IVISON H E,et al. Congenital adrenal hyperplasia and P450 oxidoreductase deficiency[J]. Clin Endocrinol(Oxf),2007,66(2):162-172. DOI:10.1111/j.1365-2265.2006.02740.x.
[2]HAO C,GUO J,GUO R,et al. Compound heterozygous variants in POR gene identified by whole-exome sequencing in a Chinese pedigree with cytochrome P450 oxidoreductase deficiency[J]. Pediatr Investig,2018,2(2):90-95. DOI:10.1002/ped4.12035.
[3]FAN L,REN X,SONG Y,et al. Novel phenotypes and genotypes in Antley-Bixler syndrome caused by cytochrome P450 oxidoreductase deficiency:based on the first cohort of Chinese children[J]. Orphanet J Rare Dis,2019,14(1):299. DOI:10.1186/s13023-019-1283-2.
[4]茅江峰,聂敏,高劲松,等. P450氧化还原酶缺陷症的临床表现和羊水穿刺产前诊断的意义[J]. 基础医学与临床,2013,33(1):24-27.
[5]李莉,刘玲,毛会英.POR基因突变致先天性肾上腺皮质增生症两家系遗传学分析[J]. 海南医学,2020,31(17):2195-2198. DOI:10.3969/j.issn.1003-6350.2020.17.006.
[6]王文萃,叶蕾,杨祖威,等. 两例细胞色素P450氧化还原酶缺陷症的临床特点和分子诊断[J]. 中华内分泌代谢杂志,2018,34(11):926-930. DOI:10.3760/cma.j.issn.1000-6699.2018.11.006.
[7]詹瑛,程璐,熊梦华,等. 细胞色素P450氧化还原酶基因突变致罕见先天性肾上腺皮质增生症一例[J]. 中华围产医学杂志,2018,21(12):825-829. DOI:10.3760/cma.j.issn.1007-9408.2018.12.007.
[8]王春庆,杨佳欣,田秦杰.细胞色素p450氧化还原酶缺乏伴卵巢黄素化囊肿1例[J]. 生殖医学杂志,2014,23(4):325-327. DOI:10.3969/j.issn.1004-3845.2014.04.015.
[9]朱志颖,吕拥芬,李嫔.细胞色素P450氧化还原酶缺陷症1例分析及文献复习[C]//浙江省医学会儿科学分会,江苏省医学会儿科学分会,上海市医学会儿科学分会.第十三届江浙沪儿科学术会议暨2016年浙江省医学会儿科学学术年会论文汇编.浙江省医学会儿科学分会,江苏省医学会儿科学分会,上海市医学会儿科学分会,浙江省科学技术协会,2016.
[10]王晓黎,白杨,李金慧,等. 由POR基因的纯合型突变R457H所导致的POR缺陷症:病例研究及文献回顾[J]. 国际内分泌代谢杂志,2017,37(3):213-216. DOI:10.3760/cma.j.issn.1673-4157.2017.03.019.
[11]白华磊.细胞色素P450氧化还原酶缺陷症2例临床分析[D]. 重庆:重庆医科大学,2019.
[12]林建立,郑俊杰,聂敏,等. P450氧化还原酶缺陷症的临诊应对[J]. 中华内分泌代谢杂志,2017,33(1):68-71. DOI:10.3760/cma.j.issn.1000-6699.2017.01.012.
[13]李洪英,董睿,张开慧,等. 一个细胞色素P450氧化还原酶缺陷症家系的临床特征及遗传学病因研究[J]. 中华医学遗传学杂志,2020,37(9):1005-1008. DOI:10.3760/cma.j.cn511374-20190912-00468.
[14]ZHANG T,LI Z,REN X,et al. Clinical and genetic analysis of cytochrome P450 oxidoreductase(POR)deficiency in a female and the analysis of a novel POR intron mutation causing alternative mRNA splicing:overall analysis of a female with POR deficiency[J]. J Assist Reprod Genet,2020,37(10),2503-2511. DOI:10.1007/s10815-020-01899-z.
[15]MILLER W L,AGRAWAL V,SANDEE D,et al. Consequences of POR mutations and polymorphisms[J]. Mol Cell Endocrinol,2011,336(1/2):174-179. DOI:10.1016/j.mce.2010.10.022.
[16]FLüCK C E,TAJIMA T,PANDEY A V,et al. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome[J]. Nat Genet,2004,36(3):228-230. DOI:10.1038/ng1300.
[17]HUANG N,PANDEY A V,AGRAWAL V,et al. Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis[J]. Am J Hum Genet,2005,76(5):729-749. DOI:10.1086/429417.
[18]FLüCK C E,MILLER W L. P450 oxidoreductase deficiency:a new form of congenital adrenal hyperplasia[J]. Curr Opin Pediatr,2006,18(4):435-441. DOI:10.1097/01.mop.0000236395.71956.5c.
[19]HOMMA K,HASEGAWA T,NAGAI T,et al. Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency:implication for the backdoor pathway to dihydrotestosterone[J]. J Clin Endocrinol Metab,2006,91(7):2643-2649. DOI:10.1210/jc.2005-2460.
[20]FUKAMI M,HASEGAWA T,HORIKAWA R,et al. Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and/or aromatase deficiency:diagnostic value of urine steroid hormone analysis[J]. Pediatr Res,2006,59(2):276-280. DOI:10.1203/01.pdr.0000195825.31504.28.
[21]ARLT W,WALKER E A,DRAPER N,et al. Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis:analytical study[J]. Lancet,2004,363(9427):2128-2135. DOI:10.1016/S0140-6736(04)16503-3.
[22]HERKERT J C,BLAAUWWIEKEL E E,HOEK A,et al. A rare cause of congenital adrenal hyperplasia:Antley-Bixler syndrome due to POR deficiency[J]. Neth J Med,2011,69(6):281-283.
[23]IDKOWIAK J,O'RIORDAN S,REISCH N,et al. Pubertal presentation in seven patients with congenital adrenal hyperplasia due to P450 oxidoreductase deficiency[J]. J Clin Endocrinol Metab,2011,96(3):E453-462. DOI:10.1210/jc.2010-1607.
[24]AGUILAR A,WU S,DE LUCA F.P450 oxidoreductase expressed in rat chondrocytes modulates chondrogenesis via cholesterol- and Indian Hedgehog-dependent mechanisms[J]. Endocrinology,2009,150(6):2732-2739. DOI:10.1210/en.2009-0043.
[25]PURSLEY T J,BLOMQUIST I K,ABRAHAM J,et al. Fluconazole-induced congenital anomalies in three infants[J]. Clin Infect Dis,1996,22(2):336-340. DOI:10.1093/clinids/22.2.336.
[26]KOYAMA Y,HOMMA K,FUKAMI M,et al. Two-step biochemical differential diagnosis of classic 21-hydroxylase deficiency and cytochrome P450 oxidoreductase deficiency in Japanese infants by GC-MS measurement of urinary pregnanetriolone/tetrahydroxycortisone ratio and 11β-hydroxyandrosterone[J]. Clin Chem,2012,58(4):741-747. DOI:10.1373/clinchem.2011.173286.